Macro view of a bright yellow flower petal with delicate orange veins

Does Time-Restricted Eating Work in PCOS?

A 6-month trial found a 6-hour eating window without calorie counting produced weight loss comparable to a 25% calorie cut in 76 women with PCOS — not a proven equal.

Both groups lost more than a no-intervention control; the two diets did not differ significantly from each other, a null with a wide confidence interval

In a 6-month randomized trial, 76 women with polycystic ovary syndrome who followed a 6-hour time-restricted eating plan without counting calories lost about as much weight as those on a 25% calorie-restriction plan — roughly 4-5% of body weight each — and both groups lost more than a no-intervention control group. The two diets did not differ significantly from each other.

What this means

In 76 women with polycystic ovary syndrome, a 6-hour eating window with no calorie counting produced about the same weight loss over six months as a 25% calorie-restriction plan — 4.32% of body weight versus 4.66% — and both groups lost more than a no-intervention control. The two diets did not differ significantly from each other: 0.34 percentage points apart, with a confidence interval running from −2.15 to 2.83, so the honest reading is that they came out comparable — which is not the same as showing one diet equals the other. Because the eating-window group was never given a calorie target, the trial cannot say whether the window itself did anything or whether eating inside six hours simply meant eating less. And all of it applies to women with polycystic ovary syndrome.

This matters because losing weight is clinically proven to be harder with Polycystic Ovary Syndrome (PCOS) because of underlying hormonal and metabolic roadblocks. Up to 70% of people with PCOS have insulin resistance, meaning the body does not use insulin well. High insulin levels tell the body to store extra glucose as fat rather than burn it for energy.

What the trial did

Researchers at the University of Illinois Chicago randomized 76 women with polycystic ovary syndrome, at a single centre, to one of three six-month arms: a 6-hour time-restricted eating plan, with all meals between 1 p.m. and 7 p.m. and no calorie tracking; a plan cutting daily calories by 25%; or a no-intervention control group that made no dietary changes. All participants received regular dietitian nutrition counselling. The primary measure was percent change in body weight at six months.

Participants were 18 to 45 years old with a body-mass index of 25 to 50 kg/m2. Women who were postmenopausal or who had type 1 or type 2 diabetes were excluded; race and ethnicity were not reported in the abstract. Only the outcomes assessor was masked — participants and dietitians knew which plan each woman was following, which is unavoidable in diet trials but leaves adherence and behaviour open to influence. The trial was registered prospectively: posted in November 2022, before the first participant enrolled in January 2023, and its registered primary outcome is the one the abstract reports.

What the trial found

At six months, the 6-hour-window group had lost 4.32% of body weight relative to the control group (95% CI −6.20 to −2.44; P<0.01), and the 25% calorie-restriction group 4.66% (95% CI −7.13 to −2.19; P<0.01). Both active arms beat the no-intervention control on the trial’s registered primary outcome.

The comparison most coverage turns on is the two diets against each other. They differed by 0.34 percentage points of body weight (95% CI −2.15 to 2.83; P=0.79) — a null between-group result whose confidence interval is wide enough to contain a meaningful advantage for either diet and no difference at all. No serious adverse events were reported.

Why this reads differently from the fasting nulls

Nutritious News has reported the result that looks like the opposite of this one. In an isocaloric 8-hour-window trial in 31 postmenopausal women, moving the same food into an 8-hour window did not improve insulin sensitivity or other cardiometabolic markers. That trial held calories equal on purpose, because it was testing whether the clock itself changes metabolism — and found it did not. This trial did the reverse: it did not match calories, and the six-hour group was told not to count them at all. It also measured weight rather than insulin sensitivity, and it ran in women with polycystic ovary syndrome, a population the trial literature has barely covered.

The PCOS evidence this sits in is small and mixed. A 2025 trial of 93 women that added an 8-hour window on top of calorie restriction found the combination lost about 3.1 kg (about 6.8 lb) more than calorie restriction alone — a positive result, but a different test, since both of its groups were counting calories. A 2026 trial of 75 women compared two different eating windows against an unrestricted control, asking which window rather than whether timing beats calories. A 2026 systematic review has since pooled that literature.

None of it answers the question this design cannot: in the six-hour group, was it the window that produced the weight loss, or the unmeasured drop in calories that a six-hour window tends to bring?

Related coverage: whether eating timing changes metabolism at all, in our earlier report on an isocaloric 8-hour window — does-time-restricted-eating-work (https://nutritiousnews.com/2026/10/01/does-time-restricted-eating-work/).

What it can’t tell you

The full paper was not available to us at press time; we read the abstract and the trial’s registry record, so methods, tables, attrition and the pre-specified analysis details could not be checked. The trial’s own contrast between the two diets is a null with a confidence interval running from −2.15 to 2.83 percentage points, and the trial was probably not powered to establish that the diets were equivalent. “Comparable” is what the data support; “proven equivalent” is not.

Because the six-hour group was never given a calorie target, the trial cannot separate the effect of the eating window from the effect of eating less without noticing. Adherence differences between the arms could also have shaped the result, and adverse-event frequency data and dropouts were not readable — only the absence of serious adverse events was reported.

The result belongs to women with PCOS. Nothing in it extends to men, to women without PCOS, or to other age groups, and women with diabetes, or who were postmenopausal, were excluded. Participants were followed for six months; durability beyond that is untested. The authors state the data are not publicly available and can be requested within 24 months.

Funding, interests and access

The trial was funded by the Department of Kinesiology and Nutrition at the University of Illinois Chicago, which states the funders were not involved in the design, conduct or analysis; no industry funder is named. The senior author (K.A.V.) received author fees from Hachette Book Group for the book The Every Other Day Diet and from Pan MacMillan Publishing for the book The Fastest Diet; the other authors declare no competing interests. Those royalties sit close to the framing of a fasting window against calorie counting.

The trial ran at the University of Illinois Chicago; the Northwestern University press release that circulated the result came from a co-author there, not from the trial site. That release also described results for several blood markers. Those figures are not in the abstract and could not be checked against the paper’s tables, so we do not report them. The full paper was not available to us at press time.

Terms explained

  • Time-restricted eating (TRE): eating within a set daily window and fasting for the rest of the day, without necessarily changing what or how much you eat. Here the window was six hours, with meals between 1 p.m. and 7 p.m.
  • Polycystic ovary syndrome (PCOS): a common hormonal condition in women of reproductive age. This trial used the Rotterdam criteria, which require at least two of raised androgens, polycystic ovaries on imaging, or infrequent or absent ovulation.
  • 25% calorie restriction: cutting daily calorie intake by a quarter, which requires estimating or tracking calories. This was the trial’s active comparison diet, not a no-treatment arm.
  • Intention-to-treat: analysing every randomized participant in the group she was assigned to, whether or not she stuck with it, so the result reflects the strategy as offered rather than only those who followed it.
  • Confidence interval: the range of values compatible with the data. A 95% interval that includes zero is compatible with no difference; this trial’s interval for the two diets against each other, −2.15 to 2.83 percentage points, is.

Sources

  1. Primary source: Corapi S, Runchey MC, Lyons J, Alonso de Leon M, Pavlou V, Lin S, Ezpeleta M, Gabel K, Tussing-Humphreys L, Oddo VM, Alexandria SJ, Sanchez J, Vidmar AP, Varady KA, Cienfuegos S. “Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial.” Nature Medicine 32(6):2155-2163, published online 2026-03-27 (issue June 2026). DOI: 10.1038/s41591-026-04316-7 · PMID: 41896647. Peer-reviewed three-arm randomized controlled trial. Abstract-level access only — full text paywalled, no PMC deposit.
  2. Trial registration: ClinicalTrials.gov NCT05629858 (“Time Restricted Eating for the Treatment of PCOS”; University of Illinois at Chicago; randomized, parallel, single masking — outcomes assessor; first posted 2022-11-29, before the actual start 2023-01-15; actual enrolment 76; primary completion 2024-12-15; status COMPLETED; primary outcome = change in percent body weight at months 0 and 6).
  3. Cross-referenced coverage (live): “Does Time Restricted Eating Work?” Nutritious News, 2026-10-01 — https://nutritiousnews.com/2026/10/01/does-time-restricted-eating-work/ (post 3427). Source study: isocaloric 8-hour TRE crossover in 31 postmenopausal women, Science Translational Medicine 2025. DOI: 10.1126/scitranslmed.adv6787 · PMID: 41160666.
  4. Landscape — PCOS TRE systematic review: “The Effects of Time-Restricted Eating in Women with Polyendocrine Metabolic Ovarian Syndrome: A Systematic Review and Meta-Analysis.” Nutrients 2026;18(13):2096. DOI: 10.3390/nu18132096 · PMID: 42451100 · PMCID: PMC13363535 (abstract-level access).
  5. Landscape — TRE added to calorie restriction in PCOS: “Time-restricted eating plus calorie-restricted diet versus calorie-restricted diet in overweight/obese women with polycystic ovary syndrome.” iScience 2025 (n=93, 16 weeks). DOI: 10.1016/j.isci.2025.113654 · PMID: 41146709 · PMCID: PMC12554142 (abstract-level access).
  6. Landscape — window-to-window comparison in PCOS: “Effect of two types of time-restricted eating on glycemic, lipid indices, and weight in women with PCOS.” European Journal of Nutrition 2026 (n=75, 6 weeks). DOI: 10.1007/s00394-026-04034-3 · PMID: 42371138 (abstract-level access).
  7. News signal (framing only, not evidence): “Time-restricted eating supports weight loss in women with PCOS.” Northwestern University (Feinberg) press release, 2026-05-12. news.feinberg.northwestern.edu. Carries the blood-marker claims that could not be verified against the paper.

Related Articles